NASDAQ:MEDS TRxADE HEALTH (MEDS) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free MEDS Stock Alerts $6.26 -0.19 (-2.95%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$5.95▼$6.7050-Day Range$4.14▼$33.9052-Week Range$3.69▼$44.56Volume20,336 shsAverage Volume344,807 shsMarket Capitalization$8.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get TRxADE HEALTH alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About TRxADE HEALTH Stock (NASDAQ:MEDS)TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.Read More MEDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MEDS Stock News HeadlinesApril 23, 2024 | globenewswire.comTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KApril 18, 2024 | msn.comLexington among cities with highest cost of prescription medications, study showsApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 17, 2024 | msn.comWhat Medications Can Cause Antiphospholipid Syndrome? A Review By DoctorsApril 17, 2024 | msn.comOn Your Side: Know this about flea and tick medicationsApril 16, 2024 | americanbankingnews.comTRxADE HEALTH (NASDAQ:MEDS) Shares Down 0.1% April 11, 2024 | msn.comThis multifunctional system can send drugs where they can be effective in body’s tissues, organsApril 11, 2024 | msn.comHundreds of drugs are in short supply around the U.S., pharmacists warnApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 1, 2024 | msn.comZenCortex Review: 180 Days Evaluation – Does This Ear Health Supplement Really Work?March 31, 2024 | msn.comThese Common Medications Could Have Terrifying Side EffectsMarch 29, 2024 | msn.comMedicare increase in spending on diabetes drugs could cost seniors more moneyMarch 29, 2024 | msn.comPopular Medications That Can Make Your Muscles WeakMarch 12, 2024 | msn.comFAIR Meds Act could impact costs for prescriptionsMarch 12, 2024 | msn.comA massive cyberattack has some Arizona health providers reeling. Here's what we knowMarch 11, 2024 | msn.comTexas health centers awarded over $19 million in grantsMarch 11, 2024 | msn.comLexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare moversMarch 6, 2024 | msn.comCrude Oil Rises Sharply; Foot Locker Shares PlungeMarch 6, 2024 | msn.comTRxADE Health Stock Skyrockets: Here's WhyMarch 6, 2024 | globenewswire.comTRxADE Health, Inc. Announces Special Cash DividendFebruary 20, 2024 | msn.comNew model identifies drugs that shouldn’t be taken togetherFebruary 20, 2024 | seekingalpha.comGCT, VHC and IPWR among mid-day moversFebruary 20, 2024 | msn.comTRxADE HEALTH Rises Over 140% - What's Going On?February 20, 2024 | msn.comWhy Is Trxade Health (MEDS) Stock Up 230% Today?February 20, 2024 | investorplace.comWhy Is Trxade Health (MEDS) Stock Up 230% Today?February 19, 2024 | msn.comThere are spurious drugs for cancer, hypertension, cholesterol, pediatric diseases…only lab tests can spot them’February 6, 2024 | msn.comIs this a scam? Prescription drugs cost 3 times more in the U.S. than in other wealthy countriesSee More Headlines Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/24/2021Dividend Payable3/22/2024Ex-Dividend for 3/22 Dividend3/25/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:MEDS CUSIPN/A CIK1382574 Webwww.trxade.com Phone(800) 261-0281Fax800-265-6932Employees33Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,470,000.00 Net Margins-78.18% Pretax Margin-43.63% Return on Equity-69.22% Return on Assets-23.52% Debt Debt-to-Equity RatioN/A Current Ratio0.61 Quick Ratio0.28 Sales & Book Value Annual Sales$8.27 million Price / Sales1.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book11.38Miscellaneous Outstanding Shares1,406,000Free Float622,000Market Cap$8.80 million OptionableNot Optionable Beta2.01 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Comp: $354.23kMr. Prashant Patel R.Ph. (Age 50)Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director Comp: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselMr. Jariel MoralesExecutive Vice PresidentDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLCMore ExecutivesKey CompetitorsCosmos HealthNASDAQ:COSMBIMINASDAQ:BIMIVapothermNYSE:VAPOIntelligent Bio SolutionsNASDAQ:INBSUniverse PharmaceuticalsNYSE:UPCView All Competitors MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed in 2024? TRxADE HEALTH's stock was trading at $5.20 at the beginning of 2024. Since then, MEDS shares have increased by 20.4% and is now trading at $6.26. View the best growth stocks for 2024 here. Are investors shorting TRxADE HEALTH? TRxADE HEALTH saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 20,500 shares, a decrease of 39.7% from the March 31st total of 34,000 shares. Based on an average trading volume of 422,000 shares, the short-interest ratio is presently 0.0 days. Currently, 2.4% of the shares of the company are sold short. View TRxADE HEALTH's Short Interest. When is TRxADE HEALTH's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our MEDS earnings forecast. How were TRxADE HEALTH's earnings last quarter? TRxADE HEALTH, Inc. (NASDAQ:MEDS) issued its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.95) by $0.45. The company earned $2.55 million during the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 69.22% and a negative net margin of 78.18%. During the same quarter in the prior year, the company posted $0.30 EPS. How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH? TRxADE HEALTH announced a dividend on Wednesday, February 28th. Shareholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th. Read our dividend analysis for MEDS. When did TRxADE HEALTH's stock split? Shares of TRxADE HEALTH reverse split on the morning of Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of TRxADE HEALTH own? Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN). How do I buy shares of TRxADE HEALTH? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MEDS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
